Vestal Point Capital, LP CYTK Holdings History
Vestal Point Capital, LP's Cytokinetics Inc Holding Summary
As of 2025-03-31, Vestal Point Capital, LP held 2.59 Mil shares of Cytokinetics Inc(CYTK), totaling $104.11 Mil. This investment constitutes 7.43% of their stock portfolio, and Vestal Point Capital, LP now holds 2.17% of the outstanding Cytokinetics Inc(CYTK) stock.
The initial trade took place in 2023Q4. And since then Vestal Point Capital, LP has made 3 purchases of CYTK, at an average price of $67.71, for a total of 3.24 Mil shares. In addition, there have been 2 sales at an average price of $56.27 for 650,000.00 shares. Based on historical transaction data and CYTK's current price of $37.23, Vestal Point Capital, LP's estimated gain on his CYTK holdings is $-86.39 Mil, reflecting a -39.37% gain to date.
Vestal Point Capital, LP CYTK ($37.23) Holding Chart
Vestal Point Capital, LP CYTK ($37.23) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
